Evolution of the Average Target: Xylem Inc.

Evolution of the Target Price: Xylem Inc.

Changes in Analyst Recommendations: Xylem Inc.

dd77d13811b1898f535b66cb5a3e.Gzy0GIb9UXepNZR_FhYNnIGYXGU2-ekmA2_YIQ8yI9c.UWTbLf6EBQf4U6cTLmU4zPPZZBBmkbtPVwnsV3YCcrtTRf53058UT84BpA~3c95cf273515c332f6605228fcd2fcdf
08-24 Jefferies Adjusts Price Target on Xylem to $150 From $145 MT
08-13 UBS Adjusts Price Target on Xylem to $138 From $135, Keeps Neutral Rating MT
08-12 Argus Adjusts Price Target on Xylem to $140 From $125, Maintains Buy Rating MT
07-30 UBS Adjusts Price Target on Xylem to $135 From $129, Maintains Neutral Rating MT
07-29 Xylem's Guidance Boost Driven by Buybacks, Bolt-On Acquisition, RBC Says MT
07-29 RBC Raises Price Target on Xylem to $164 From $159, Keeps Outperform Rating MT
07-29 Deutsche Bank Adjusts Xylem Price Target to $151 From $149, Maintains Buy Rating MT
07-29 JPMorgan Adjusts Price Target on Xylem to $137 From $130, Maintains Neutral Rating MT
07-29 Barclays Adjusts Price Target on Xylem to $159 From $154, Maintains Overweight Rating MT
07-29 Baird Adjusts Price Target on Xylem to $165 From $163, Maintains Outperform Rating MT
07-29 Stifel Adjusts Price Target on Xylem to $160 From $157, Maintains Buy Rating MT
07-29 Goldman Sachs Adjusts Price Target on Xylem to $160 From $153, Maintains Buy Rating MT
07-29 Citigroup Adjusts Price Target on Xylem to $172 From $168, Maintains Buy Rating MT
07-29 Mizuho Adjusts Price Target on Xylem to $130 From $124, Maintains Neutral Rating MT
07-21 JPMorgan Downgrades Xylem to Neutral From Overweight, Cuts Price Target to $130 From $140 MT
07-20 Jefferies Adjusts Price Target on Xylem to $145 From $140, Maintains Buy Rating MT
07-20 Stifel Adjusts Price Target on Xylem to $157 From $159, Maintains Buy Rating MT
07-16 RBC Capital Adjusts Price Target on Xylem to $159 From $157, Maintains Outperform Rating MT
07-14 Xylem Likely Approaching Growth Inflection, Oppenheimer Says MT
07-06 UBS Adjusts Xylem Price Target to $129 From $133 MT
06-25 Xylem Shares Rise After Jefferies Upgrade MT
06-25 Jefferies Upgrades Xylem to Buy From Hold, Adjusts Price Target to $140 From $130 MT
05-19 Argus Adjusts Price Target on Xylem to $125 From $150, Maintains Buy Rating MT
04-29 Mizuho Adjusts Price Target on Xylem to $124 From $138, Maintains Neutral Rating MT
04-29 Oppenheimer Adjusts Price Target on Xylem to $158 From $160, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+45.59%
+20.61%
+23.94%
+18.76%
+26.05%
+29.36%
+28%
+5.95%
+62.54%
+15.63%
Average +27.64%
Weighted average by Cap. +25.49%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
105.69USD
Average target price
153.88USD
Spread / Average Target
+45.59%
High Price Target
180.00USD
Spread / Highest target
+70.31%
Low Price Target
129.00USD
Spread / Lowest Target
+22.06%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. XYL Stock
  4. Consensus Xylem Inc.